Barclays
CNTG

Barclays’s Centogene N.V. Common Shares CNTG Stock Holding History

Barclays’s Portfolio CNTG Stock Details CNTG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-15,348
Closed -$3.99K – 5589
2024
Q3 		$3.99K Hold
15,348
– – ﹤0.01% 5045
2024
Q2 		$5.83K Hold
15,348
– – ﹤0.01% 4564
2024
Q1 		$10.9K Hold
15,348
– – ﹤0.01% 4799
2023
Q4 		$18.4K Hold
15,348
– – ﹤0.01% 4919
2023
Q3 		$16.3K Hold
15,348
– – ﹤0.01% 4217
2023
Q2 		$23K Hold
15,348
– – ﹤0.01% 4108
2023
Q1 		$10K Hold
15,348
– – ﹤0.01% 4753
2022
Q4 		$14.3K Sell
15,348
-310
-2% -$282 ﹤0.01% 4873
2022
Q3 		$18K Sell
15,658
-317
-2% -$517 ﹤0.01% 4105
2022
Q2 		$38K Sell
15,975
-73
-0.5% -$229 ﹤0.01% 4148
2022
Q1 		$68K Buy
+16,048
New +$67.3K ﹤0.01% 3967

Barclays's CNTG Position: Q4 2024 in Review

Barclays sold out of Centogene N.V. Common Shares (CNTG) in Q4 2024, closing a stake of 15,348 shares — an estimated $3.99K sold.

Barclays first reported a position in CNTG in Q1 2022 and held it in 11 quarters. The position peaked at $68K in Q1 2022. 0 funds tracked by Wall St. Rank hold CNTG as of Q4 2024.

  • Barclays reported no remaining Centogene N.V. Common Shares position as of Q4 2024 after selling out during the quarter.
  • Barclays sold 15,348 Centogene N.V. Common Shares shares in Q4 2024, an estimated $3.99K.
  • Barclays first reported a position in Centogene N.V. Common Shares in Q1 2022 and held it in 11 quarters.
  • Barclays's Centogene N.V. Common Shares position peaked at $68K in Q1 2022.
  • 0 funds tracked by Wall St. Rank held Centogene N.V. Common Shares as of Q4 2024.

Based on Barclays's 13F filing for Q4 2024, filed 13 Feb 2025.